Clotting factor-fc chimeric proteins to treat hemophilia
US8449884B2 · kind B2 · utility
67Cited by
61References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2010 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Nov 18, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a chimeric protein comprising at least one clotting factor and at least a portion of an immunoglobulin constant region. The invention relates to a method of treating a hemostatic disorder comprising administering a therapeutically effective amount of a chimeric protein wherein the chimeric protein comprises at least one clotting factor and at least a portion of an immunoglobulin constant region.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.